Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users.
Laurence SlamaRaphael PorcherFrançoise LinardCatherine ChakvetadzeAgnès CrosSéverine CarillonLucille GallardoJean-Paul ViardJean-Michel MolinaPublished in: BMC infectious diseases (2023)
PWH and PrEP users expressed a high level of interest in LAA, since a large majority seems to be in favor of this new approach. Further studies should be conducted to better characterize targeted individuals.